MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Wednesday, June 22, 2016

12:00pm-1:30pm
GAA expansion with clinic/urodynamic findings in Friedreich’s ataxia with LUTS

P.N.S. Almeida, A.F.A. Musegante, U. Barroso (Salvador, Brazil)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
GAITRite comparison between Parkinson’s disease stages

W. Deeb, D. Martinez-Ramirez, J. Giugni, M. Okun, C. Hass (Gainesville, FL, USA)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Gender and age-based differential item functioning (DIF) analysis of MDS-UPDRS

C.G. Goetz, L. Wang, G.T. Stebbins, B.C. Tilley, S. Luo (Chicago, IL, USA)

Clinical Phenomenology and Rating Scales
12:00pm-1:30pm
Gender differences in DLB: frequency, clinical presentation and treatment

S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease

I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir (Sevilla, Spain)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Globus pallidus interna oscillatory activity differentiates tics from voluntary movements and the Parkinsonian resting state

J. Jimenez-Shahed, I. Telkes, A. Viswanathan, N.F. Ince (Houston, TX, USA)

Neurophysiology (non-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients

C. Uribe, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, A.I. Garcia-Diaz, A. Campabadal, A. Abos, C. Junque (Barcelona, Spain)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Handwriting in Parkinson′s disease: Systematic review and preliminary study

C. Simonet, A.J. Noyce, H. Ling, A.J. Lees, T.T. Warner (Segovia, Spain)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 54
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley